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Interaction  of  several cells has  been shown  to  be required  in  the  immune 
response of mice to sheep red blood cells  (SRBC)*  (1,  2).  The bone marrow- 
derived  lymphocyte apparently functions  as  the  antibody-forming precursor 
cell  (AFPC)  after  contact  in  an  unknown  fashion  with  a  thymic-influenced 
lymphocyte (2-5). Thus, when antibody synthesis in neonatally thymectomized 
(NTx)  mice was restored by injection  of donor,  viable, thymic lymphocytes, 
19S hemolysin-producing cells in the spleen of the recipient were shown to be 
derived from the host and of bone marrow origin (2). However, while thymic 
lymphocytes may not  differentiate  to  become antibody-forming cells  in  this 
system,  they  nevertheless  respond  to  antigenic  stimulation  by  proliferation 
(6, 7), and have been termed antigen-reactive cells (ARC). 
Evidence that  the macrophage may be one of the cell types stimulated by 
the  potent  adjuvant  action  of homoribopolynucleotide complexes  2 (8,  9)  was 
recorded  in  the  preceding  manuscript  (10).  The  effect of polyadenylic-poly- 
uridylic  acid  complexes (poly A:U)  on  thymic-influenced  and  bone marrow- 
derived cells in the model system of Miller and Mitchell (2) are presented herein, 
and  the  experiments described  suggest  that  an  additional  mode  of  action  of 
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poly A:U  in enhancing antibody synthesis is to expand a  small population of 
thymic-influenced cells. No  effect on  bone marrow cells was  apparent. 
Materials and Methods 
Animals.--BALB/Aj mice originally derived from those of Dr. William Murphy, Depart- 
ment  of  Microbiology, The  University of  Michigan  (11),  were inbred in  our  laboratory. 
C57BL/6j  mice were obtained from Jackson Laboratories, Bar  Harbor,  Maine.  The mice 
were fed Purina mouse chow and water ad libitum. New Zealand white rabbits approximately 
1-2 kg were obtained from a local supplier. 
Antlgen.--SRBC  were obtained from the Colorado Serum Company, Denver, Colo.  The 
cells were stored at 4°C in modified Alsever's solution, washed three times, and resuspended in 
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FIG.  1.  Restoration of immune response of neonatally thymectomized mice by  thymic 
]ymphocytes.  Mice  received  4 X  l0  s  SRBC 4-th)nnic  lymphocytes  intravenously  and 
spleens were removed 6 days later and assayed for RFC. Each point represents the arithmetic 
mean of three separate experiments with four to five mice per group in each experiment. 
phosphate-buffered  saline (PBS), pH 7.2, for injection. In all instances mice received 4 X  10  s 
SRBC intravenously. 
ttomoribopolynucleotides.--Polyadeny|ic acid  (poly A) potassium salt  (lots 110748,  11-57- 
301)  and polyuridylic acid  (poly U) ammonium salt (lots 411754,  11-6-308) were purchased 
from Miles Laboratories, Elkhart, Ind. Each polymer was stored at  -20°C at a concentra- 
tion of 15  mg/ml in PBS, pH 7.2. Polymers were complexed in vitro to form poly A:U by 
mixing equal amounts of the polynucleotides before use  . 
Heterologous Anti-Thymocyte Serum.--Anti-mouse  thymocyte serum  (ATS)  was prepared 
by the method of Gray eta|. (12). Single cell suspensions of thymic lymphocytes from 5-wk 
old female BALB/Aj mice were washed three times and resuspended in PBS, pH 7.2.  The 
washed suspension was mixed with an equal volume of Freund's complete adjuvant  (Difco 
Laboratories, Detroit, Mich.) and injected into the footpads of NZW rabbits such that each 
rabbit received 1 X  10 s  thymic lymphocytes. 4  wk  later the rabbits received intravenous 
injections of thymic lymphocytes in PBS for 3 consecutive days for a  total of 3 X  l0  s cells. 
The rabbits were bled 7 and 10 days after the late injection. Each serum was absorbed with 
SRBC and BALB/Aj mouse RBC and stored at --20°C. The antiserum was found to agghiti- ROBERT  E.  CONE AND  ARTHUR  G.  JOHNSON  667 
nate thymic lymphocytes to a  dilution of 1:512.  0.4 ml or more antiserum injected intra- 
peritoneally 2-3 days before an intravenous injection of SRBC resulted in maximum (90?95%) 
suppression of the immune response to SRBC as measured by the rosette technique. In all 
cases the serum was inactivated by heating at 56°C for 30 min before use. 
Cell Preparations.--Single cell suspensions  of thymic lymphocytes  used to prepare ATS or to 
restore thymectomized or irradiated mice were obtained by mincing the thymic lobes of 4-5- 
wk old BALB/Aj mice in cold PBS, 7.2. The cell suspension was passed through a  No. 80 
gauge stainless steel mesh into PBS, washed three times, and resuspended in PBS, pH 7.2, to 
appropriate concentrations. Suspensions of bone marrow cells were prepared from 9-10-wk 
old Balb/Aj mice. The marrow was flushed from femurs and tibias by means of a syringe and a 
26  gauge needle containing cold Eagle's basal medium. ,The extruded plugs were dispersed 
by aspiration with a  21  gauge needle and  the cells were washed three times in cold PBS, 
7.2,  and  resuspended to  an  appropriate  volume. 
Thymectomy.--18-24-hr old mice were thymectomized according to the method of Sjodin 
et al.  (13). Mice were anesthetized with ether and a longitudina  !  incision was made into the 
mediastinal cavity to the level of the fourth rib. The thymic lobes were removed by aspira- 
tion and the wound was closed with a single silk suture. Before removal of spleens for rosette 
analysis, the mice were examined with the aid of a dissecting microscope for the presence of 
thymic remnants. Mice with thymic remnants were excluded from the study. 
Transplantation.--BALB/Aj  mice were the  recipients of  skin  from  5-6-wk  old  female 
C57BL/6j mice. Recipient mice were anesthetized with pentobarbital anesthesia and the skin 
was removed from their backs in whole thickness in the shape of a rectangle approximately 
2 ;K 2 cm. A skin fragment of a  slightly larger size was removed from the abdomen of the 
donor and sutured in place using 5-0 surgical  thread. The mice were housed separately and 
observed each day for signs of rejection. 
Irradiation.--BALB/Aj  mice, 9-10-wk old were exposed to 800 R  whole-body irradiation 
at a distance of 100 cm from a ~°Co source delivering 67 R/min. 
Rosette Assa~.--6 days after injection of SRBC, the immune response to SRBC was meas- 
ured by the rosette assay (14, 15).  Spleens from each experimental group were pooled, dis- 
persed, and washed in PBS, pH 7.2. To 1 ml of the washed, monodisperse spleen cell suspen- 
sion was added 0.1 m] of a 10% suspension of washed SRBC; this mixture was incubated for 
1.5 hr at 37°C and overnight at 4°C. SRBC adhere to cells producing anti-SRBC antibody to 
form a "rosette." Rosette-forming  cells (RFC) were enumerated by counting the spleen cell- 
SRBC  mixture in a  hemocytometer at  200  X  magnification. Approximately 5,000-10,000 
spleen cells were counted, depending on individual experiments. 
RESULTS 
Restoration  of the Immune Response to SRBC in NTx Mice by Thymic Lym- 
phocytes  or Poly A : U.--The ability of thymic lymphocytes to restore in our 
system  an  immune  response impaired  by neonatal  thymectomy is  shown  in 
Fig. 1. It may be seen that NTx reduced by 90 % the numbers of RFC occurring 
in response to SRBC, while l0  s thymic lymphocytes restored the response of 
NTx mice back to 54% of normalcy. 
In  testing  whether  poly A:U  exerted  its  adjuvant  action  on  the  thymic 
lymphocyte in this system, the effect of poly A:U alone, without lymphocytes 
in  NTx  mice,  also  was  determined.  Surprisingly,  NTx  mice  injected  intra- 
venously with SRBC plus poly A:U at a concentration of 1200 ~g (600 ~g of 
each polymer) were restored on day 6 to full immunocompetence with respect 668  POLYNUCLEOTIDE  REGULATION  OF  THE  IMMUNE  SYSTEi~.  III 
to RFC, in the absence of injected thymic lymphocytes (Fig. 2). As the quantity 
of poly A: U  was lessened, the number of RFC produced decreased as a straight- 
line function. 
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Fro. 2. Restoration of immune response in neonatally thymectomized  mice by poly A:U. 
Mice received  4 X  10  8 SRBC  4- poly A:U intravenously. Spleens were  removed 6  days 
]ater and pooled for RFC assay. Each point represents the arithmetic mean of three separate 
experiments with four to five mice per group  in each experiment. 
TABLE I 
Restoration  of Homograft Rejection  in NTx Mice by Poly A : U 
Mice injected with 
Mean survival time (days) 
Unoperated  No. of mice  Tx  No. of mice 
13.5  6  24.0  7 
(4-0.8)*  (4-3.0) 
Poly A:U  12.0  6  13.0  8 
(+1.3)  (4-3.2) 
BALB/Aj recipients received whole-thickness  skin grafts  from  C57BL/6j  donors.  Mice 
receiving poly A: U were injected with 600 #g intraperitoneally 12, 24, and 72 hr after grafting. 
* () indicates 95% confidence interval. 
Since neonatal thymectomy depresses cellular immunity as well as circulat- 
ing antibody to SRBC,  the experimental procedure was extended to determine 
whether NTx  mice treated with poly A:U  alone would regain the capacity to 
reject skin homografts. Accordingly, NTx and unoperated BALB/Aj mice were 
grafted with skin from C57BL/6j  donors.  Groups of NTx  and unoperated re- 
cipients received 600  ~g of poly A:U intraperitoneally 12,  24,  and 72  hr after ROBERT  E.  CONE  AND  ARTHUR  G.  JOHNSON  669 
grafting. As can be seen in Table I, skin grafted on mice with an intact thymus 
had a mean survival time of 13.5 days, while the mean survival time of grafts 
on NTx mice was  extended  to 24  days.  However, NTx mice which  received 
poly A:U were able to reject grafts at the same rate as unoperated mice. Thus, 
cellular as well as humoral immunity appeared to be restored by poly A:U in 
NTx  mice,  corroborating  earlier  studies  on  the  effect  of  poly A:U  on  cell- 
mediated immune reactions (16). 
Restoration  of Immune Response to SRBC in Normal Mice Treated with A TS 
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Fie. 3. Restoration of immune response in ATS-treated mice by poly A:U. Mice received 
4 X  l0  s SRBC 4-poly A:U intravenously 3 days after intraperitoneal injection of 0.4 ml 
ATS. Spleens were assayed for RFC 6 days after injection of antigen. Each point represents 
the arithmetic mean of three separate experiments with three to four mice per group in each 
experiment. 
by Poly A : U. To confirm the competence of poly A: U in overcoming inhibiting 
effects on lymphocytes, a different approach was utilized where injection of ATS 
was substituted for neonatal thymectomy. Accordingly, varying doses of poly 
A:U along with  SRBC  were injected into normal mice 3  days after they re- 
ceived intraperitoneally 0.4 ml of ATS. Splenic RFC were assayed 6 days after 
the  injection  of  antigen.  As  can be seen in  Fig.  3,  untreated  mice produced 
42,000 RFC/10 ~ spleen cells while mice pretreated with ATS produced only 5 % 
of this  number.  1200  /~g of poly A:U increased  the response of ATS-treated 
mice 10-fold. As was the case with poly A:U administered to NTx mice, when 
the quantity of poly A:U was lessened, the number of RFC produced decreased. 
From the preceding data it was evident that poly A:U injection could readily 
replace the need for thymic lymphocytes in animals depleted of such cells. It 
was not apparent, however, whether  the restorative effects of poly A:U con- 670  POLYNUCLEOTIDE  REGULATION  OF  THE  IMMUNE  SYSTEM.  III 
stituted  an actual replacement of a  polynucleotide-like hormone from thymic 
lymphocytes or whether  its  effects were dependent  on the  amplification of a 
small number of residual  thymic cells which might have seeded or influenced 
the peripheral lymphoid tissue before thymectomy. 
In testing this question,  it was reasoned that if both thymectomy and ATS 
treatment  were  combined,  the  number  of  any  residual  cells  bearing  thymic 
influence  would  be  decreased  further  than  with  either  treatment  alone. 
If poly A:U action was based on amplifying these cells,  its effect should have 
been reduced if the number of cells to be amplified were reduced. If poly A: U 
were simply replacing the need for hormone action on a  nonthymic cell,  then 
decreasing the residual cells remaining after thymectomy should have no effect 
on poly A: U enhancement. The results agreed with the amplification hypothesis 
TABLE  II 
Resloratlon of Immune Response in  Thymectomized and 
Thymeclomized 4- A TS-Treated ~Iice 
RFC/10~ spleen cells 
Products  injected  Thymectomized  ATS only  Thymectomized 
Unoperated  only  q- ATS 
SRBC  23,000  1600  2000  615 
SRBC 4- poly A: U  N.D.  11,700  9700  2000 
Mice received 4  N  108 SRBC ±  600 #g poly A:U intravenously 3  days after intraperito- 
neal  injection  of 0.4  ml ATS.  Values  represent  arithmetic  mean of  three  separate  experi- 
ments with four to five mice per group in each experiment. 
N. D.  =  not done. 
and are as follows: NTx mice received ATS intraperitoneally 3 days before an 
intravenous  injection  of  SRBC  or  SRBC  and  poly A:U.  As may be  seen  in 
Table II, unoperated mice produced 23,000 RFC/106 spleen cells. Thymectomy 
or ATS treatment reduced the immune response by 90% to 1600-2000 RFC/10 a 
spleen cells.  Combination of thymectomy and ATS treatment reduced further 
the  RFC  response  to  615  RFC/106  spleen  cells.  When  NTx or ATS-treated 
mice  received  600  /zg  of  poly A:U  the  expected  degree  of  restoration  was 
achieved.  However,  although  poly A:U  was  able  to  elevate  the  immune  re- 
sponse 4-fold in mice receiving both thymectomy and ATS treatment, the total 
number of RFC ultimately produced was diminished, parallelling the reduction 
in  the  number  of  thymic  antigen-reactive  cells  achieved  by  combination  of 
thymectomy and ATS treatment. 
The  results  presented  in  Table II suggested  that  the  ability  of poly A:U 
to restore immunocompetence to NTx mice was dependent on the expansion of 
a  small number  of ARC  which  might be present  in  the peripheral lymphoid 
tissue before thymectomy. Since lethally irradiated mice require both thymic- ROBERT  E.  CONE  AND  ARTHUR  G.  JOHNSON  671 
derived  and  bone  marrow-derived  cells  to  produce  an  immune  response  to 
SRBC (1),  this model system was employed to distinguish  any possible effects 
of  poly A:U  on  thymic  ARC  and/or  AFPC  of  bone  marrow  origin.  Thus, 
unoperated mice which received 800 R  whole-body irradiation 24 hr previously 
were  injected  with  either  4  X  10  s  SRBC,  SRBC  and  thymic  lymphocytes, 
SRBC  and  bone  marrow  cells,  or  SRBC  and  a  combination  of  the  two  cell 
types. Spleens were assayed for RFC 9 days after the injection of antigen. 
No increase  in RFC was found in the  spleens  of irradiated  mice which re- 
10 5 
No  poly  A:U 
=  ~.  +  poly  A:U 
10 3  I  I 
I0  4  I0  5  IO  s  10  7 
Number  of  Thymic  Lymphocytes  Injected 
FIG.  4.  Effect  of poly A:U on the immune response of irradiated  mice receiving grade 
numbers of thymus cells and a constant number of bone marrow cells. Mice received 800 R 
whole-body irradiation and 24 hr later received intravenously  107 bone marrow cells, 4 X  10  s 
SRBC, and graded numbers of thymic lymphocytes -4- 600/zg poly A:U. Spleens from each 
group were removed 9 days after injection of cells and antigen, pooled, and assayed for RFC. 
The average  number of RFC/spleen  was  determined  by computing  the  total  number of 
RFC/number of mice in each group. Each point represents the results obtained with five to 
six mice per group. 
ceived SRBC only or SRBC plus bone marrow cells,  as expected.  Mice which 
received  SRBC  and  a  combination  of thymic lymphocytes and bone marrow 
cells  had  1.8  N  105  RFC/spleen  which was  63  times  as many RFC  as  mice 
receiving SRBC  and  thymic cells  only,  (2.9  X  10  ~ RFC).  Thus,  the need for 
both bone marrow cells and thymic-influenced lymphocytes in the restoration 
of immunocompetency under these conditions was demonstrated. 
With this established,  the possibility that poly A:U could amplify the func- 
tion of small numbers of ARC was studied by injecting lethally irradiated mice 
with  poly A:U  and  graded  numbers  of thymic lymphocytes plus  a  constant 
number in excess of bone marrow cells and antigen. Using minimal replacement 
levels of thymus cells (4 X  104-5  N  106),  a pronounced effect of poly A:U on 
thymic cells was seen, as is shown in Fig. 4. Thus, the addition of poly A:U to 672  POLYNUCLEOTIDE  REGULATION  OF  THE  IMMUNE  SYSTEM.  III 
just 40,000 thymic lymphocytes enabled the expression of an immune response 
in irradiated mice receiving bone marrow cells and SRBC. This low number of 
thymocytes without poly A:U was nonfunctional. The immunoenhancing effect 
of poly A:U decreased as the number of thymic lymphocytes injected was in- 
creased,  suggesting that with higher numbers  of thymus  cells, the number  of 
bone  marrow  cells became  a  limiting factor  in  the  expression  of  an  immune 
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FI~. 5. Effect of poly A:U on the immune  response of irradiated mice receiving graded 
numbers of marrow cells and a constant number of thymus cells. Mice received 800 R whole- 
body irradiation and 24 hr later received intravenously 10  s thymic lymphocytes, 4 X  108 
SRBC, graded numbers of bone marrow cells 4- 600/zg poly A:U. Spleens from each group 
were removed 9 days after injection of cells and antigen, pooled, and assayed for RFC. The 
average number of RFC/spleen was determined by computing the total number of RFC/ 
number of mice in each group.  Each point represents  the results obtained with five to six 
mice per group. 
response.  Thus,  when ARC  were  present  in  excess  of  AFPC,  the  maximum 
number  of  thymus-marrow  cell  interactions  probably  occurred,  and  further 
increases in  the number  of ARC would not  elevate the number  of RFC  pro- 
duced. 
To  test for  any effect of poly A: U  on  bone  marrow  cells,  irradiated mice 
were injected in like experiments with graded numbers  of bone marrow cells, 
SRBC, poly A:U, and a constant number,  108, of thymic lymphocytes. Spleens 
were removed on day 9 and assayed for RFC. As can be seen in Fig. 5, the hum- ROBERT  E.  CONE  AND  ARTHUR  G.  JOHNSON  673 
ber of RFC per spleen increased from 5  X  10  3 to 1.2  X  10  5 as the number of 
bone marrow cells injected was increased from 2 X  10  6 to 4  X  10  7. However, 
when poly A:U was injected with 2 X  10  6 or 10  7 bone marrow cells, no adjuvant 
effect was observed. Only when the number of bone marrow cells was increased 
to 4 X  10  7, such that the thymocytes became limiting, did a rise in RFC become 
apparent  with  poly A:U  treatment.  This  probably  reflected  action  on  the 
thymocyte and not the bone marrow cell. 
DISCUSSION 
The ability of poly A:U to restore the RFC response in NTx- or ATS-treated 
mice supports the hypothesis that this adjuvant exerts its action on the thymic- 
influenced ARC,  in addition to the effect on the macrophage recorded in the 
preceding manuscript (10). That thymectomy or ATS treatment reduced the 
number  of  thymic-influenced ARC  necessary for  the  full  expression  of  im- 
munocompetence  is  documented  by  the  ability  of  thymic  lymphocytes  to 
restore RFC as well as the PFC response of NTx- or ATS-treated mice (2, 17, 
18). As RFC have been shown to be actively synthesizing antibody (19, 20) and 
antibody-forming cells are of bone marrow rather than thymic origin (3-5), it 
is unlikely that thymic lymphocytes were functioning as RFC precursors, but 
rather  as ARC.  That thymic lymphocytes in  this  system do not  end up  as 
RFC is also suggested by the fact that irradiated mice which received a com- 
bination of thymic lymphocytes and bone marrow cells produced 63-fold more 
RFC than irradiated mice receiving thymic lymphocytes and SRBC only. The 
observation (8)  that poly A:U shortened the time required for the attainment 
of the peak number of PFC responding to SRBC might suggest that the poly- 
nucleotides stimulated  the proliferation of AFPC  after such  cells interacted 
with ARC. This is probably not the case inasmuch as poly A:U injected 1 day 
after antigen in normal mice did not exert any adjuvant effect3 
Experiments by Shearer and Cudkowicz indicate that one of the first steps 
in  the  initiation  of  the  immune  response  to  SRBC  is  an  antigen-dependent 
proliferation  Of  thymic-derived ARC  (7).  Accordingly,  poly A:U  might  in- 
fluence the rate of activation and/or proliferation of ARC, thus amplifying the 
small number of ARC  which were present in  the peripheral lymphoid tissue 
before, and persisting after thymectomy, as attested by the further reduction in 
RFC in NTx mice by ATS treatment.  Such a possibility is supported by the 
observation that  poly A:U  allowed the  detection of an  immune response in 
irradiated  mice  receiving bone  marrow  cells,  SRBC,  and  as  few  as  40,000 
thymic lymphocytes. The decreased adjuvant action of poly A:U as the bone 
marrow  cell  population  became  limitingl  further  emphasizes  that  thymic 
lymphocytes, rather than the bone marrow cells,  are stimulated by the homo- 
ribopolymers. In addition, experiments in progress in which thymic lymphocytes 
were incubated with poly A:U  in vitro before injection into thymectomized 674  POLYNUCLEOTIDE  REGULATION  OF  THE  IMMUNE  SYSTEM.  III 
mice indicate that poly A:U exerts its  stimulatory effect directly on  thymic 
lymphocyte membranes when increasing immunocompetence in NTx mice. 
The restoration of immunocompetence in NTx mice by the implantation of 
thymus organs in diffusion chambers (21, 22) or the injection of cell-free extracts 
of thymic tissue (23, 24) has led to the suggestion that the thymus may secrete 
a  competence-inducing humoral factor. This raises  the  question whether  the 
polynucleotides  act  like  a  thymic  hormone.  However,  the  lessening  of  the 
adjuvant action of poly A:U  as  the number of residual  thymocytes in NTx 
mice was decreased further by ATS treatment, as well as the inability of poly 
(A:U) to restore RFC in irradiated mice reconstituted with bone marrow cells 
only, argue against  this possibility. It is  important, however, that  in experi- 
ments involving the use of thymic extracts and NTx animals attention be given 
to the fact that small numbers of residual thymic cells remain which might be 
stimulated to a remarkable degree by nucleic acids released on extraction of the 
thymus,  acting  like poly A:U  to restore competency. 
SUIVIMARY 
Polyadenylic-polyuridylic acid complexes, a potent adjuvant to the immune 
response,  were  tested  for  action  on  thymic-influenced  and  bone  marrow- 
derived lymphocytes in model systems deficient in one or the  other of these 
cells. 
Adult mice, thymectomized at birth or mice treated with heterologous anti- 
thymocyte serum produced  90--95 %  fewer splenic rosette-forming cells  than 
normal  mice  in  response to  an  injection  of  sheep  erythrocytes. Intravenous 
injection  of  complexes  of  homoribopolynucleotides,  polyadenylic  and  poly- 
uridylic  acids,  poly A:U  with  SRBC  restored  immunologic  competence  to 
NTx-  or ATS-treated mice such  that  they produced normal  or near normal 
levels of splenic RFC. In addition, injection of poly A:U enabled NTx mice to 
reject allogeneic skin grafts at  the same rate  as control mice with  an intact 
thymus.  Further  reduction  in  residual  thymocytes  by  combining  neonatal 
thymectomy with ATS treatment reduced the number of anti-SRBC RFC in- 
duced by poly A:U. 
Lethally irradiated mice which  received SRBC,  excess bone marrow cells, 
and  as few as 40,000  thymic lymphocytes were stimulated  by poly A:U  to 
produce RFC. No adjuvant effect was observed when irradiated mice received 
excess thymic lymphocytes and low doses of bone marrow cells with poly A:U. 
The results suggested that the adjuvant action of poly A:U was exerted on 
the  thymic-influenced, antigen-reactive cell and  that  restoration of immuno- 
competence to NTx-  or ATS-treated mice was  caused by amplification of a 
small number of residual antigen-reactive cells  which were influenced by the 
thymus in  utero  before thymectomy, or which survived treatment with  ATS. ROBERT  E.  CONE  AND  ARTHUR  G.  JOHNSON  675 
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